Crossref
The missing comparator: Why MS drug risks are clear, but MS disease risks are not
Advances in Clinical Neuroscience & Rehabilitation · 2026
DOI: 10.47795/akar7136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical Neuroscience & Rehabilitation, 2026. Verfasst von Dominic Shadbolt. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shadbolt, D. (2026). The missing comparator: Why MS drug risks are clear, but MS disease risks are not. Advances in Clinical Neuroscience & Rehabilitation. https://doi.org/10.47795/akar7136
Vancouver
Shadbolt D. The missing comparator: Why MS drug risks are clear, but MS disease risks are not. Advances in Clinical Neuroscience & Rehabilitation. 2026. doi:10.47795/akar7136
BibTeX
@article{Shadbolt2026,
author = {Shadbolt, Dominic},
title = {The missing comparator: Why MS drug risks are clear, but MS disease risks are not},
journal = {Advances in Clinical Neuroscience & Rehabilitation},
year = {2026},
doi = {10.47795/akar7136}
}
EUVIMED